The same mechanism creates reflux conditions
If metformin at a maximum tolerated dose does not achieve the HbA1c target after 3 months, add a second oral agent (a sulfonylurea [SU], thiazolidinedione [TZD], dipeptidyl peptidase 4 [DPP-4] inhibitor, or sodium-glucose cotransporter-2 [SGLT2] inhibitor), a glucagon-like peptide-1 (GLP-1) receptor agonist, or a basal insulin ( TABLE 2 )
I also carry the negative variant of the TCF7L2 gene, which impacts GLP-1 levels
Maintain regular follow-ups and open communication with your provider about your progress and discuss any concerns related to cost, insurance, the availability of the medication, and potential side effects
Clinically, a lesion may be mistaken for a benign pigmented lesion, a reactive process, or an anatomic variation
Polymorphisms in serotonin-receptor genes, variants in the calcitonin pathway, or pre-existing dysbiosis characterized by methane-producing archaea may forecast susceptibility to nausea, gall-bladder events, or constipation, respectively
.webp)
